Seguir
Tiago Fleming Outeiro
Tiago Fleming Outeiro
University Medical Center Goettingen, Goettingen, Germany
Dirección de correo verificada de gwdg.de - Página principal
Título
Citado por
Citado por
Año
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
91612021
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease
TF Outeiro, E Kontopoulos, SM Altmann, I Kufareva, KE Strathearn, ...
science 317 (5837), 516-519, 2007
11402007
Yeast cells provide insight into alpha-synuclein biology and pathobiology
TF Outeiro, S Lindquist
Science 302 (5651), 1772-1775, 2003
9412003
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
C Hansen, E Angot, AL Bergström, JA Steiner, L Pieri, G Paul, TF Outeiro, ...
The Journal of clinical investigation 121 (2), 715-725, 2011
8832011
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein
S Willingham, TF Outeiro, MJ DeVit, SL Lindquist, PJ Muchowski
Science 302 (5651), 1769-1772, 2003
5152003
Formation of toxic oligomeric α-synuclein species in living cells
TF Outeiro, P Putcha, JE Tetzlaff, R Spoelgen, M Koker, F Carvalho, ...
PloS one 3 (4), e1867, 2008
4632008
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
B Mollenhauer, V Cullen, I Kahn, B Krastins, TF Outeiro, I Pepivani, J Ng, ...
Experimental neurology 213 (2), 315-325, 2008
4272008
SIRT1 and SIRT2: emerging targets in neurodegeneration
G Donmez, TF Outeiro
EMBO molecular medicine 5 (3), 344-352, 2013
3892013
Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington’s and Parkinson’s diseases
RA Bodner, TF Outeiro, S Altmann, MM Maxwell, SH Cho, BT Hyman, ...
Proceedings of the National Academy of Sciences 103 (11), 4246-4251, 2006
3332006
Alpha-synuclein: from secretion to dysfunction and death
O Marques, TF Outeiro
Cell death & disease 3 (7), e350-e350, 2012
3322012
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease
M Martins, A Rosa, LC Guedes, BV Fonseca, K Gotovac, S Violante, ...
PloS one 6 (10), e25443, 2011
2582011
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation
MJ Diógenes, RB Dias, DM Rombo, HV Miranda, F Maiolino, P Guerreiro, ...
Journal of Neuroscience 32 (34), 11750-11762, 2012
2542012
Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro
IL Derkatch, SM Uptain, TF Outeiro, R Krishnan, SL Lindquist, ...
Proceedings of the National Academy of Sciences 101 (35), 12934-12939, 2004
2412004
Protein phosphorylation in neurodegeneration: friend or foe?
S Tenreiro, K Eckermann, TF Outeiro
Frontiers in molecular neuroscience 7, 42, 2014
2402014
Interactions among α-synuclein, dopamine, and biomembranes
JC Rochet, T Fleming Outeiro, KA Conway, TT Ding, MJ Volles, ...
Journal of Molecular Neuroscience 23 (1), 23-33, 2004
2302004
Small heat shock proteins protect against α-synuclein-induced toxicity and aggregation
TF Outeiro, J Klucken, KE Strathearn, F Liu, P Nguyen, JC Rochet, ...
Biochemical and biophysical research communications 351 (3), 631-638, 2006
2292006
α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B
DG Ferreira, M Temido-Ferreira, H Vicente Miranda, VL Batalha, ...
Nature neuroscience 20 (11), 1569-1579, 2017
2122017
Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation
DF Lázaro, EF Rodrigues, R Langohr, H Shahpasandzadeh, T Ribeiro, ...
PLoS genetics 10 (11), e1004741, 2014
2102014
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models
LJ Su, PK Auluck, TF Outeiro, E Yeger-Lotem, JA Kritzer, DF Tardiff, ...
Disease models & mechanisms 3 (3-4), 194-208, 2010
2072010
Dementia with Lewy bodies: an update and outlook
TF Outeiro, DJ Koss, D Erskine, L Walker, M Kurzawa-Akanbi, D Burn, ...
Molecular neurodegeneration 14 (1), 1-18, 2019
2022019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20